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Summary.-In 104 patients with gastric cancer the serum proteins carcinoembryonic
antigen (CEA), C-reactive protein (CRP), oil-acid glycoprotein (AGP) (orosomu-
coid) and a, -antichymotrypsin (ACT) were measured pre-operatively. The estimated
median survival of patients with both raised CEA and ACT was only 5 weeks in
contrast to 64 weeks for those with both proteins normal. An intermediary group
with one of these proteins raised and the other normal had an estimated median
survival of 15 weeks. Similar results were obtained by considering a combination of
CEA with either AGP or CRP, For these data the results were not explicable in terms
of associations between survival time and patient's age, stage, operative procedure,
histological classification or site of primary tumour.
DESPITE the considerable advances
which have been made in the early diagno-
sis of gastric cancer by the wider use of
endoscopy and improved radiological tech-
niques, most patients with this disease,
except those in Japan, are at an advanced
stage at their first presentation to hospital,
and this is reflected in their short survival
time. About 11,000 new cases of stomach
cancer are registered each year in England
and Wales.
Surgery is the only curative treatment.
The survival time of patients eventually
dying of the disease is strongly influenced
by several factors: whether a potentially
curative or only a palliative operation
was possible (Cady et al., 1977), the pre-
sence and extent of metastases (Remine
& Priestley, 1966), the histology (Hawley
et al., 1970) and the general clinical state
of the patients. Study of other forms of
cancer has suggested that the pre-treat-
ment levels of certain serum proteins may
carry prognostic information additional
to that given by clinical factors (Wanebo
et al., 1978; O'Quigley et al., 1981). In
this study we have investigated the
association between postoperative survival
time and pre-treatment levels of carcino-
embryonic antigen, albumin and 3 acute-
reactant proteins (APRPs). To assess to
what degree any association discovered
was independent of clinical findings, the
patient's age, stage, type of operation,
site of primary tumour and histological
classification were recorded.
PATIENTS AND METHODS
For over 2 years a set of patients in Leeds,
diagnosed as having gastric cancer, was
studied. At the close ofthe study, 104 patients
had been accrued, their pre-operative blood
samples, taken and their subsequent post-
operative survival monitored. Diagnosis was
generally based upon a combination of radio-
logical examination and endoscopy, though
in a small proportion of cases only one
investigation w-as used. Histological con-
firmation was obtained in 92% of cases, the
remainder being mainly patients with obvious
advanced cancer in whom gastroenterostomy
or laparotomy was performed. The main
sub-groups into wNhich patients fell are
outlined in the Table.
Ten ml of blood was taken before surgery,
allowed to clot and the serum separated
and stored at -20°C until analysed. Carcino-
embryonic antigen (CEA) was measured in
duplicate on unextracted serum, using aBIOLOGICAL EFFECTS OF TREMOLITE
solid-phase double-antibody technique (Ham-
marstrdm & Berglund, 1979). This assay
gave an upper limit of normal of 8 ng/ml,
which corresponded to a level of 5 ng/ml
using the Abbott CEA-EIA assay on per-
chloric acid-extracted sera. In this study a
CEA > 10 ng/ml was considered to be high.
Serum cxl-antichymotrypsin (ACT), oil-acid
glycoprotein (AGP) and C-reactive protein
(CRP) were measured by single radial
immunodiffusion (Mancini et al., 1965) using
antisera and standards obtained from Beh-
ringwerke, Marburg, Germany and Seward
Laboratories, London. The upper limits of
normal for these proteins were defined as:
ACT 0-8 g/l; AGP 1-4 g/l and CRP 10 mg/l.
These levels were adopted on the basis of
earlier experience in a study of elderly
patients (Bastable et al., 1979). Serum
albumin was measured colorimetrically in
multi-channel analysers, 37 g/l being the
lower limit of normal.
Stati8tical approach. The methods de-
scribed by Peto et al. (1977) were used to
examine differences in survival between
groups defined according to the different
serum levels. Whereas these methods are
appropriate in the case of randomized
clinical trials, here they are being used to
examine prognostic factors. The approach
should therefore be regarded as an explora-
tory one, in which the significance levels
(P values) would not have their usual
interpretation. This is particularly so when
a number of questions are being asked of the
data. None the less, all else being equal, small
P values suggest the implausibility that
observed differences arose by random varia-
tion. It is because all else was not usually
equal that stratification as described in the
above mentioned paper was carried out. This
helped to show whether any differences were
simply explicable by clinical imbalance in
the groups.
RESULTS
All the patients in this study irrespec-
tive of the stratification variables out-
lined in the Table, were divided into 2
groups according to whether the CEA was
within normal limits or elevated (> 10
ng/ml). The survival experience of the
2 groups was significantly different; the
median survival in the patients with a
normal CEA was 28 weeks and in the
TABLE.-Description of patients and
clinical variables used in stratification.
Age range (years
35-89 (median 70)
Sex
60 males, 44 females
Stage
A (8%) tumour localized to the stomaclh with-
out obvious lymph-node iinvolvement
B (19%) local lymph-node involvement
C (73%) distant metastases including involve-
ment of the coeliac group of lymph
nodes; also tumours in which stomach
was fixed to adjacent structures
Primary tumour site
Cardia or fundus (24%)
Body (33%)
Antral and pyloric regions (37%)
Wlhole stomach (6%)
Histology
Well differentiate(l (9%)
Poorly differentiated (570%)
"Interme(liate" (34%)
Operative procedure
Partial or total gastrectomy (57%)
Gastroenterostomy (13%)
Inoperable (30%)
patients with a raised CEA it was 10
weeks (P < 0-001). Applying a similar
procedure, when the patients were divided
into 2 groups according to whether a
particular acute-phase reactant protein
(APRP) was elevated or normal, it was
observed that the patients with normal
APRP levels had a significantly longer
survival than those with raised levels.
This was true for all 3 APRPs, ACT
being the most marked. Forty-six patients
witha normal ACT had a median survival
of 53 weeks, compared to 59 patients with
a raised value and median survival of
only 9 weeks (P < 0001). The separations
achieved with AGP and CRP were very
similar to one another, in that the median
survival time in the non-raised group was
>40 weeks, compared with < 12 weeks
in the elevated group (P < 0 01).
It was noted that if any one of ACT,
AGP or CRP were raised, there was a
high probability that the other 2 APRPs
would also be raised. On the other hand,
there was a lack of correlation between a
high CEA and high APRP. Since both
were shown to have prognostic value,
this lack of correlation suggested that a
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DISCUSSION
The overall 5-year survival for gastric
cancer in Europe and North America still
remains between 5 and 15%, reflecting
the poor prognosis of the disease, despite
general advances in surgery and suppor-
tive care (Gilbertson, 1969; Lundh et al.,
1974; Dupont et al., 1978). There have
been many studies of the factors that
influence prognosis in gastric cancer.
Stage is obviously important (Adashek
et al., 1979); on the other hand, opinion
varies on the role of structural features
and histological differentiation of the tu-
mour (Black et al., 1971; Lauren, 1965;
Syrjanen & Hjelt, 1977), the type of
resection (Eker & Ejskind, 1960; Lewin,
1960; Lumpkin et al., 1964), tumour site,
size and type (Cady et al., 1977; Remine
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& Priestley, 1966; Hawley et al., 1970)
and length of history (Barber et al. 1961;
Swynnerton & Truelove, 1952). The com-
bination of stage and histology has
previously provided the surest basis for
assessing prognosis and is made after
laparotomy.
The pre-operative assessment of prog-
nosis in patients without evident meta-
stasis is very difficult; often the full
extent of the disease is seen only at
laparotomy or after the study of the
resected specimen. This clearly adds to
the surgeon's difficulty in deciding the
most suitable operative procedure.
The tests described in this paper have
the advantage of giving prognostic infor-
mation before surgery, and can be pro-
vided within a few days. Furthermore the
statistical analysis has indicated that this
system may still have prognostic signi-
ficance even after stage has been taken
into account. There is growing evidence
that in some forms of cancer high CEA
carries a high probability of a poor
prognosis, for example, pre-operative CEA
in colon cancer and the time to recur-
rence are inversely correlated (Wanebo
et at., 1978). A weak negative association
between pre-operative CEA levels and
survival in stomach cancer has been
reported (Freeman et al., 1979). Similarly,
in breast cancer (Steward et al., 1974),
lung cancer (Vincent et al., 1975; Ford et
al., 1981) and gynaecological cancer (van
Nagell et al., 1977) a raised CEA carries a
high probability of extensive disease and
a poor prognosis. Acute-phase reactant
proteins rise nonspecifically in many
forms of cancer (Cooper & Stone, 1979).
Raised APRPs before treatment are
associated with a poor prognosis, as
judged by survival, in category T3 and
T4 bladder cancer (O'Quigley et al., 1981)
and in carcinoma of the bronchus (Brad-
well et al., 1980).
This preliminary study suggests that a
simple combination of tests may add to
the clinician's knowledge about his pat-
ient. It is perhaps permature to say that
these tests should influence clinical deci-
sions; e.g. to substitute a simple pro-
cedure such as laparoscopy for laparo-
tomy when the evidence suggests a poor
prognosis, in the absence of symptoms
requiring surgical palliation. A more
practical application would seem to be
as an aidto stratification for chemotherapy
trials.
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